Foley Equipped

Foley Attorneys Discuss Preparation for New U.S. Outbound Investment Regime

Foley & Lardner LLP partners Louis Lehot and Christopher Swift are quoted in the IFLR article, “Law firms prep market for US outbound investment regime,” offering insight on how companies can approach the expected impact of new rules restricting outbound investment in advanced technologies and countries of concern to national security. “Many clients are asking whether they […]

Foley Represents TCGX as a Lead Investor in $285M Financing for COMPASS Pathways

Foley & Lardner LLP represented TCGX as a lead investor in the $285 million financing for COMPASS Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. TCGX led the round with Aisling Capital. They were joined by additional investors Vivo Capital, RA Capital, Surveyor Capital (a Citadel company), Paradigm […]

Foley Represents TCGX as a Lead Investor in $200M Series C Financing for ADARx

Foley & Lardner LLP represented TCGX as a lead investor in the oversubscribed $200 million Series C financing for ADARx, a leader in next generation RNA Therapeutics. TCGX led the round jointly with Bain Capital Life Sciences. ADARx is a clinical stage biotechnology company committed to turning cutting-edge science into life-saving therapeutics. ADARx has developed […]

Increased Litigation From Various Website Tracking Technologies

This article was originally published in Westlaw Today on September 6, 2023 . Within the last year, there has been a new wave of class action lawsuits targeting a wide array of companies that own and operate websites (also known as “website operators”), including, but not limited to, streaming services, entertainment companies, professional sports leagues and, in […]

Foley Represents TCGX in $200M Private Placement Financing for Inhibrx

Foley & Lardner LLP represented TCGX as a co-lead investor in the $200 million private placement financing for Inhibrx, a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases. The round was co-led by RA Capital Management, Viking Global Investors, and Perceptive Advisors. Inhibrx is a clinical-stage biopharmaceutical company focused […]

New Kids on the Block: Navigating the Newest Consumer Group in Privacy (Teens)

October 6, 2023 | San Diego, CA As part of the 2023 IAPP Privacy. Security. Risk conference, Avi Ginsberg (Associate, Boston) will be joining a panel discussing the impact of teens on data privacy. As the privacy landscape continues to evolve, so does the classification of consumers they govern. In an industry that was historically […]

Subscribe to our newsletter
Subscribe

© 2025 Foley & Lardner LLP
Attorney Advertisement
Images of people may not be Foley personnel.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome.